• Explore /
  • Poster
  • / LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers.

LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers.

Abstract Poster

Authors

null

Boris Sepesi

Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Boris Sepesi , David Randolph Jones , Bryan F. Meyers , Jamie E. Chaft , Lynette M. Sholl , Yu Shyr , Karen Kelly , Jules Lin , Paul A. Bunn Jr., John D. Minna , Valerie W. Rusch , Ignacio Ivan Wistuba , David J. Kwiatkowski , David Paul Carbone , Lynne D. Berry , Jay M. Lee , Khaled Tolba , Mark G. Kris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04712877

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS8596)

DOI

10.1200/JCO.2022.40.16_suppl.TPS8596

Abstract #

TPS8596

Poster Bd #

219a

Abstract Disclosures

Similar Posters

First Author: Benjamin J. Solomon

First Author: Mo Yang

First Author: Makenzi Colleen Evangelist

First Author: John Leonard Fox